In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies.
Saved in:
| Title: | In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies. |
|---|---|
| Authors: | Mattei AE; EpiVax, Inc, Providence, RI, USA., Gutierrez AH; EpiVax, Inc, Providence, RI, USA., Seshadri S; EpiVax, Inc, Providence, RI, USA., Tivin J; EpiVax, Inc, Providence, RI, USA., Ardito M; EpiVax, Inc, Providence, RI, USA., Rosenberg AS; EpiVax, Inc, Providence, RI, USA., Martin WD; EpiVax, Inc, Providence, RI, USA., De Groot AS; EpiVax, Inc, Providence, RI, USA. |
| Source: | MAbs [MAbs] 2024 Jan-Dec; Vol. 16 (1), pp. 2333729. Date of Electronic Publication: 2024 Mar 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1942-0870 |
|---|---|
| DOI: | 10.1080/19420862.2024.2333729 |
